T1	Participants 83 119	patients with chronic kidney disease
T2	Participants 176 234	patients with chronic kidney disease (CKD) not on dialysis
T3	Participants 869 926	Patients (n = 113) with stage 3-4 CKD and evidence of CAC
T4	Participants 1982 2050	patients with absent or moderate but not accelerated CAC progression
